Additional file 2 of Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study

Autor: Bouwmans, P., Messchendorp, A. L., Sanders, J. S., Hilbrands, L., Reinders, M. E. J., Vart, P., Bemelman, F. J., Abrahams, A. C., van den Dorpel, M. A., Ten Dam, M. A., de Vries, A. P. J., Rispens, T., Steenhuis, M., Gansevoort, R. T., Hemmelder, M. H.

Additional file 2. Questionnaires at 6, 12 and 24 months after vaccination.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328d304de808ba050f2f65434121a368

Differences in Hemodynamic Performance and Modality Measurements Between Self-Expanding Versus Balloon-Expanding Valves in ViV-TAVI Patients with Failed Aortic Bioprosthesis (FAB-TAVI Study).

Autor: Chatterjee, S.¹ (AUTHOR), van den Dorpel, M.¹ (AUTHOR), Adrichem, R.¹ (AUTHOR), Verhemel, S.¹ (AUTHOR), Kardys, I.¹ (AUTHOR), Nuis, R.-J.¹ (AUTHOR), Daemen, J.¹ (AUTHOR), Ren, C. Ben¹ (AUTHOR), Hirsch, A.¹ (AUTHOR), Geleijnse, M.L.¹ (AUTHOR), van Mieghem, N.M.¹ (AUTHOR)

Publikováno v: Cardiovascular Revascularization Medicine. 2024 Supplement, Vol. 65, p81-82. 2p.

800.14 Differences in Hemodynamic Performance and Modality Measurements Between Self-Expanding Versus Balloon-Expanding Valves in ViV-TAVI Patients with Failed Aortic Bioprosthesis (FAB-TAVI Study)

Autor: Chatterjee, S., van den Dorpel, M., Adrichem, R., Verhemel, S., Kardys, I., Nuis, R.-J., Daemen, J., Ben Ren, C., Hirsch, A., Geleijnse, M.L., van Mieghem, N.M.

Publikováno v: In JACC: Cardiovascular Interventions 26 February 2024 17(4) Supplement:S69-S69

Protein-bound uremic toxins in hemodialysis patients relate to residual kidney function, are not influenced by convective transport, and do not relate to outcome

Autor: van Gelder, Maaike K, Middel, Igor R, Vernooij, Robin W M, Bots, Michiel L, Verhaar, Marianne C, Masereeuw, Rosalinde, Grooteman, Muriel P, Nubé, Menso J, van den Dorpel, M A, Blankestijn, Peter J, Rookmaaker, Maarten B, Gerritsen, Karin G F, Afd Pharmacology, Pharmacology

Publikováno v: van Gelder, M K, Middel, I R, Vernooij, R W M, Bots, M L, Verhaar, M C, Masereeuw, R, Grooteman, M P, Nubé, M J, van den Dorpel, M A, Blankestijn, P J, Rookmaaker, M B & Gerritsen, K G F 2020, ' Protein-bound uremic toxins in hemodialysis patients relate to residual kidney function, are not influenced by convective transport, and do not relate to outcome ', Toxins, vol. 12, no. 4, 234 . https://doi.org/10.3390/toxins12040234
Toxins
Volume 12
Issue 4
Toxins, 12(4). MDPI AG
Toxins, 12(4):234. Multidisciplinary Digital Publishing Institute
Toxins, Vol 12, Iss 234, p 234 (2020)

Protein-bound uremic toxins (PBUTs) are predominantly excreted by renal tubular secretion and hardly removed by traditional hemodialysis (HD). Accumulation of PBUTs is proposed to contribute to the increased morbidity and mortality of patients with e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e360fda38a477017c7308ce3870aed
https://research.vumc.nl/en/publications/214fcf4d-c275-4be6-a93a-9df7d751e534

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.